GPER G-1 DEVELOPMENT GROUP
GPER G-1 Development Group develops a novel therapeutic for the treatment of diabetes and obesity. The company’s leading drug candidate for the treatment of obesity (through weight loss) and the treatment of diabetes and pre-diabetes (by restoring insulin sensitivity and glucose homeostasis) is Tespria, the GPER agonist G‑1.
GPER G-1 DEVELOPMENT GROUP
Industry:
Health Care Health Diagnostics Medical Therapeutics
Website Url:
http://www.gperg1.com
Status:
Active
Similar Organizations
3X Genetics
3X Genetics develops medical screening solutions to identify genetic disorders.
Endobetix
A Non-Surgical Solution to Treat Type 2 Diabetes and Obesity
Gismo Therapeutics
Gismo Therapeutics, a biotechnology startup, develops small-molecule therapeutics for the treatment of Alzheimer’s and Parkinson’s diseases.
I Heart Care
I Heart Care help keep track of health information both electronically and printed.
Innovative Healthcare
Innovative Healthcare develops therapeutics for the treatment of diabetes and chronic wounds.
POTS Treatment Center
The POTS Treatment Center offers patients collaborative, alternative care aimed at treating the whole person, not just the disorder.
Official Site Inspections
http://www.gperg1.com
- Host name: 130.0.153.160.host.secureserver.net
- IP address: 160.153.0.130
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "GPER G-1 Development Group"
A Novel Therapeutic for the treatment of diabetes & obesity
Solution. G-1 (Tespria) is revolutionary in that it modulates energy expenditure in the absence of changes in food intake or activity. It targets metabolic activity “brown fat” cells, treats obesity …See details»
GPER G-1 Development Group - Crunchbase Company Profile
GPER G-1 Development Group develops a novel therapeutic for the treatment of diabetes and obesity. The company’s leading drug candidate for the treatment of obesity (through weight …See details»
Leadership Team – GPER G-1 Development Group
GPER G-1 Development Group is a New Mexico Start-Up Factory portfolio company. The New Mexico Start-Up Factory specializes in sourcing and transitioning laboratory technologies into investable companies.See details»
GPER G-1 Development Group - Overview, News & Similar
Who is GPER G-1 Development Group. The GPER G-1 Development Group is a drug discovery and development company with the primary goal of advancing novel drug candidates that …See details»
GPER G-1 Development Group LLC - VentureRadar
Similar Companies: Linnaeus Therapeutics USA n/a Linnaeus Therapeutics, Inc. is a privately held biopharmaceutical company focused on the development and commercialization of novel, …See details»
GPER G-1 Development Group - LinkedIn
GPER G-1 Development Group | 22 followers on LinkedIn. A Novel Drug Candidate for the Treatment of Diabetes and Obesity. | Diabetes is a growing concern globally—it is a leading …See details»
GPER G-1 Development Group - Datanyze
Www.gperg1.com . Contact Information. Headquarters. 101 Broadway Blvd NE Ste 1100, Albuquerque, New Mexico, 87102, United States (505) 843-1347. GPER G-1 Development …See details»
GPER G-1 Development Group LLC - Drug pipelines, Patents, …
Explore GPER G-1 Development Group LLC with its drug pipeline, therapeutic area, technology platform, 2 news.See details»
GPER G-1 Development Group LLC - VentureRadar
Website: http://gperg1.com/ GPER-G-1 is a drug development company with the primary goal of advancing novel drug candidates discovered at the University of New Mexico ...See details»
GPER G-1 Development Group - PitchBook
Jul 10, 2020 gperg1.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 101 Broadway Boulevard North East; Street 1100; …See details»
GPER G-1 Development Group - SignalHire
Organization Website: gperg1.com : GPER G-1 Development... industries Pharma: GPER G-1 Development... Employees Size 1-10 employees: Founded: 2018: GPER G-1 Development …See details»
Get in Touch – GPER G-1 Development Group
Get in touch. If you’d like more information about our company, please fill out the form below and a member of our team will get in touch with you.See details»
Gper G-1 Development Group LLC in Albuquerque, NM - (505) …
Gper G-1 Development Group LLC is in the Business Activities At Non-Commercial Site business. View competitors, revenue, employees, website and phone number.See details»
GPER G-1 Development Group | F6S
Similar companies Phyteau, Inc. A new approach for diabetes, obesity, weight-loss & metabolic syndrome. Idun Biologics Enhanced protein replacement therapy against obesity and …See details»
News – GPER G-1 Development Group
Sep 25, 2020 The organization specializes in business creation, business growth, intellectual property and technology commercialization. Arrowhead is a touchstone for collaborate efforts …See details»
Gper G-1 Development Group - Company Contact Details
See company details and contact information for Gper G-1 Development Group as well as related information and industry data.See details»
UNM Startup GPER G-1 Development Group Receives STTR Grant
Jul 21, 2020 The National Institutes of Health (NIH) via the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded a $300,000 grant to GPER G-1 …See details»
GPER G-1 Development Group receives STTR Grant for the …
GPER-1 Development Group LLC has licensed the promising technology from the University of New Mexico and New Mexico State University . PRESS RELEASE: JULY 15, 2020 …See details»
Science – GPER G-1 Development Group
Nov 12, 2019 Researchers at the University of New Mexico have recently characterized the novel G protein-coupled Estrogen Receptor (GPER) as a novel therapeutic target for obesity …See details»
Treatment – GPER G-1 Development Group
GPER-1 Development Group LLC has licensed the promising technology from the University of New Mexico and New Mexico State University PRESS RELEASE: JULY 15, …See details»